Literature DB >> 6805918

Serum calcium regulating hormones in the perinatal period.

Y Seino, M Ishida, K Yamaoka, T Ishii, T Hiejima, C Ikehara, Y Tanaka, S Matsuda, T Shimotsuji, H Yabuuchi, S Morimoto, T Onishi.   

Abstract

To clarify perinatal vitamin D metabolism, we measured 25-hydroxyvitamin D (25OHD), 24,25-dihydroxyvitamin D [24,25(OH)2D], 1,25-dihydroxyvitamin D [1,25(OH)2D], calcium (Ca), phosphorus (P), parathyroid hormone (PTH), and human calcitonin (CT) in paired maternal, cord, and infant serum. Cord serum 25OHD was significantly lower than the maternal level, and cord serum 24,25(OH)2D was also significantly below the maternal concentrations. Maternal, cord, and infant serum 1,25(OH)2D, on the other hand, was significantly higher than the normal adult level. The serum PTH was low, but the CT concentration was high in the cord. Cord serum Ca and P levels were significantly higher than maternal. The reason for the elevated circulating 1,25(OH)2D level in the perinatal period is uncertain, and we speculate that the possible factors are gonadal steroids, placental lactogen, prolactin, and CT. In addition, serum 24,25(OH)2D and 1,25(OH)2D concentrations are under some control by the fetus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805918     DOI: 10.1007/BF02411223

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  20 in total

1.  The measurement of the vitamin D-binding protein in human serum.

Authors:  R Bouillon; H van Baelen; P de Moor
Journal:  J Clin Endocrinol Metab       Date:  1977-08       Impact factor: 5.958

2.  Effect of growth hormone on vitamin D metabolism.

Authors:  E Spanos; D Barrett; I MacIntyre; J W Pike; E F Safilian; M R Haussler
Journal:  Nature       Date:  1978-05-18       Impact factor: 49.962

3.  Salmon calcitonin-induced stimulation of 1 alpha,25-dihydroxycholecalciferol synthesis in rats involving a mechanism independent of adenosine 3':5'-cyclic monophosphate.

Authors:  N Horiuchi; H Takahashi; T Matsumoto; N Takahashi; E Shimazawa; T Suda; E Ogata
Journal:  Biochem J       Date:  1979-11-15       Impact factor: 3.857

4.  Serial measurements of serum calcium, magnesium, parathyroid hormone, calcitonin, and 25-hydroxy-vitamin D in premature and term infants during the first week of life.

Authors:  L S Hillman; S Rojanasathit; E Slatopolsky; J G Haddad
Journal:  Pediatr Res       Date:  1977-06       Impact factor: 3.756

5.  Fetal plasma prolactin levels.

Authors:  A J Winters; C Colston; P C MacDonald; J C Porter
Journal:  J Clin Endocrinol Metab       Date:  1975-09       Impact factor: 5.958

6.  Vitamin D homeostasis in the perinatal period: 1,25-dihydroxyvitamin D in maternal, cord, and neonatal blood.

Authors:  J J Steichen; R C Tsang; T L Gratton; A Hamstra; H F DeLuca
Journal:  N Engl J Med       Date:  1980-02-07       Impact factor: 91.245

7.  A specific competitive protein binding assay for serum 24,25-dihydroxyvitamin D in normal children and patients with nephrotic syndrome.

Authors:  T Shimotsuji; T Hiejima; Y Seino; K Yamaoka; T Ishii; M Ishida; S Matsuda; C Ikehara; H Yabuuchi
Journal:  Clin Chim Acta       Date:  1980-09-25       Impact factor: 3.786

8.  Comparison of human calcitonin secretion after a 1-minute calcium infusion in young normal and in elderly subjects.

Authors:  S Morimoto; T Onishi; Y Okada; K Tanaka; M Tsuji; Y Kumahara
Journal:  Endocrinol Jpn       Date:  1979-04

9.  Relations of plasma 25-hydroxyvitamin D levels in mothers, cord blood and newborn infants, and postnatal changes in plasma 25-hydroxy-vitamin D levels.

Authors:  T Shimotsuji; Y Seino; M Ishida; T Ishii; C Ikehara; T Hiejima; H Yabuuchi
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  1979       Impact factor: 2.000

10.  Concentrations of 24,25-dihydroxyvitamin D and 25-hydroxyvitamin D in paired maternal-cord sera.

Authors:  Y Weisman; M Occhipinti; G Knox; E Reiter; A Root
Journal:  Am J Obstet Gynecol       Date:  1978-03-15       Impact factor: 8.661

View more
  12 in total

Review 1.  Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications.

Authors:  Carol L Wagner; Bruce W Hollis; Kalliopi Kotsa; Hana Fakhoury; Spyridon N Karras
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

2.  Determinants and Measurement of Neonatal Vitamin D: Overestimation of 25(OH)D in Cord Blood Using CLIA Assay Technology.

Authors:  Mengdi Lu; Bruce W Hollis; Vincent J Carey; Nancy Laranjo; Ravinder J Singh; Scott T Weiss; Augusto A Litonjua
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 3.  Global summary of maternal and newborn vitamin D status - a systematic review.

Authors:  Rajneeta Saraf; Susan M B Morton; Carlos A Camargo; Cameron C Grant
Journal:  Matern Child Nutr       Date:  2015-09-15       Impact factor: 3.092

4.  Decreased bone density in severely handicapped children and adults, with reference to the influence of limited mobility and anticonvulsant medication.

Authors:  S Nishiyama; T Kuwahara; I Matsuda
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

Review 5.  The role of vitamin D in pregnancy and lactation: emerging concepts.

Authors:  Carol L Wagner; Sarah N Taylor; Donna D Johnson; Bruce W Hollis
Journal:  Womens Health (Lond)       Date:  2012-05

6.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.

Authors:  D D Bikle; E Gee; B Halloran; J G Haddad
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

7.  Activity of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase in a case of X-linked hypophosphataemic rickets.

Authors:  Y Seino; K Satomura; K Yamaoka; Y Tanaka; H Tanaka; T Yamamoto; M Ishida; H Yabuuchi
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

8.  Increased circulating levels of gamma-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy.

Authors:  N Takeshita; Y Seino; H Ishida; Y Seino; H Tanaka; C Tsutsumi; K Ogata; K Kiyohara; H Kato; M Nozawa
Journal:  Calcif Tissue Int       Date:  1989-02       Impact factor: 4.333

9.  Evidence that calcitonin plays a role in the postnatal increase of serum 1 alpha,25-dihydroxyvitamin D.

Authors:  T Nishioka; T Yasuda; H Niimi; H Nakajima
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

10.  Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis.

Authors:  R Civitelli; D Agnusdei; P Nardi; F Zacchei; L V Avioli; C Gennari
Journal:  Calcif Tissue Int       Date:  1988-02       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.